| Upcoming events on SAGE THERAPEUTICS, INC. |
|
| 02/25/21 | | FY 2020 Earnings Release (Projected) |
| 05/06/21 | | Q1 2021 Earnings Release (Projected) |
| 08/10/21 | | Interim 2021 Earnings Release (Projected) |
| 11/11/21 | | Q3 2021 Earnings Release (Projected) |
|
| Past events on SAGE THERAPEUTICS, INC. |
|
| 01/12/21 | 10:50am | | JP Morgan Healthcare Conference |
| 12/09/20 | 03:00pm | | BMO Capital Markets Boston Growth Conference |
| 11/30/20 | 08:00am | | Biogen Inc and Sage Therapeutics, Inc Gobal Collaboration and License Agreement Call |
| 11/19/20 | 04:05pm | | Wolfe Virtual Healthcare Conference |
|
| Upcoming sector events for SAGE THERAPEUTICS, INC. |
|
|
| |
|
| Past sector events for SAGE THERAPEUTICS, INC. |
|
|
|
|
|
| Annual results | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 (e) |
Sales
M $ |
Released
Forecast
Spread |
|
|
| 90,3
90,0
0,30% | 6,87
8,72
-21% |
7,04
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | -94,5
-93,3
-1,4% | -160
-140
-14% | -273
-285
4,4% | -392
-375
-4,5% | -706
-736
4,0% |
-479
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -94,7
-93,5
-1,3% | -160
-144
-11% | -273
-282
3,2% | -393
-369
-6,6% | -708
-728
2,8% |
-483
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -94,5
-94,0
-0,56% | -159
-144
-10% | -270
-279
3,0% | -373
-347
-7,4% | -680
-701
2,9% |
-471
|
Net income
M $ |
Released
Forecast
Spread | -94,5
-93,4
-1,2% | -159
-144
-10% | -270
-279
3,3% | -373
-349
-6,8% | -680
-700
2,9% |
-473
|
EPS
$ |
Released
Forecast
Spread | -3,40
-3,35
-1,6% | -4,75
-4,38
-8,4% | -7,09
-7,38
3,9% | -8,08
-7,54
-7,1% | -13,4
-13,8
2,7% |
-9,07
| | Announcement Date | 02/24/2016 | 02/23/2017 | 02/22/2018 | 02/19/2019 | 02/27/2020 | |
|
|
|
| Quarterly results | 2018 Q2 | 2018 Q3 | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 (e) | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) |
Sales
M $ |
Released
Forecast
Spread | 90,0
|
| 0,27
| 0,47
| 0,87
0,27
223% | 3,57
2,52
41% | 1,96
3,76
-48% | 2,30
2,81
-18% | 1,09
0,88
24% | 1,64
1,85
-11% |
10,1
|
161
|
18,5
|
29,1
|
21,5
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | -21,9
-94,8
77% | -128
-125
-2,9% | -164
-145
-13% | -169
-170
0,35% | -176
-178
0,94% | -186
-183
-1,8% | -174
-204
15% | -131
-178
26% | -110
-141
22% | -107
-137
22% |
-113
|
360
|
-80,1
|
-85,5
|
-88,5
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | -22,1
-88,4
75% | -129
-116
-11% | -164
-141
-16% | -170
-161
-5,3% | -176
-175
-1,0% | -187
-182
-2,6% | -175
-194
10% | -132
-171
23% | -111
-141
22% | -108
-127
15% |
-48,5
|
4,62
|
-78,3
|
-69,5
|
-84,3
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | -17,0
-86,6
80% | -123
-112
-9,8% | -158
-136
-16% | -163
-154
-5,8% | -168
-169
0,46% | -180
-176
-2,1% | -169
-189
11% | -127
-167
24% | -136
-143
4,9% | -106
-127
17% |
-30,8
|
35,7
|
-72,0
|
-60,4
|
-77,9
|
Net income
M $ |
Released
Forecast
Spread | -17,0
-87,1
81% | -123
-113
-8,6% | -158
-138
-15% | -163
-156
-4,6% | -168
-169
0,71% | -180
-176
-2,1% | -169
-188
10% | -127
-166
24% | -136
-140
2,6% | -106
-125
15% |
-115
|
-77,7
|
-73,2
|
-63,3
|
-79,1
|
EPS
$ |
Released
Forecast
Spread | -0,36
-1,91
81% | -2,63
-2,42
-8,6% | -3,38
-2,94
-15% | -3,37
-3,26
-3,5% | -3,28
-3,38
3,0% | -3,48
-3,41
-2,1% | -3,25
-3,62
10% | -2,44
-3,19
24% | -2,63
-2,69
2,3% | -2,03
-2,37
14% |
-1,05
|
0,13
|
-1,29
|
-1,15
|
-1,37
| | Announcement Date | 08/07/2018 | 11/06/2018 | 02/19/2019 | 05/02/2019 | 08/06/2019 | 11/12/2019 | 02/27/2020 | 05/07/2020 | 08/10/2020 | 11/05/2020 | | | | | |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
Previous period
